GlobeNewswire Inc.··NaInventiva to Report 2025 Results as MASH Drug Candidate Advances in Phase 3
Inventiva to release 2025 financial results March 30, 2026, as its lanifibranor MASH drug advances through Phase 3 clinical trials.
IVAPhase 3 clinical trialfinancial results